Tags: FDA

8/24/2018

Without an independent source, BuzzFeed’s story on a medical device for OCD doesn’t offer much beyond the news release

5 10/25/2017

Brief but informative report from AP on newly approved shingles vaccine

7/18/2017

Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000

4/14/2017

Lack of independent sources hinders AP story on new drug that treats side effect caused by antipsychotics

1/8/2016

Tacos and neural tube defects: NPR deftly explains the connection

1 11/13/2015

WSJ whiffs on meaningful aspects of new melanoma drug approval — including $17,600/month price tag

2/17/2012

Weight-Loss Drugs Face High Hurdles At FDA

2/1/2012

FDA Approves Cystic Fibrosis Drug

4/18/2011

FDA Approves New Device for Brain Tumor Treatment

2/5/2011

FDA Approves First Drug To Prevent Preterm Births

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

National Breast Cancer Coalition @NBCCStopBC·

A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold

Reply on Twitter 1520768892888567810 Retweet on Twitter 15207688928885678101 Like on Twitter 15207688928885678103 Twitter 1520768892888567810

HealthNewsReview.org @HealthNewsRevu·

Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's ⁦@CarlaKJohnson⁩. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d

Reply on Twitter 1516522980385472513 Retweet on Twitter 1516522980385472513 Like on Twitter 15165229803854725134 Twitter 1516522980385472513